Onconaut
Wilmington, United States
Onconaut Therapeutics Incorporated (OTI), A Delaware C-Corporation and Colorado-registered company, is developing precision medicines against molecular targets promoting tumor progression, metastasis, and multi-drug resistance. Lead drugs being developed by OTI are designed to address the unmet needs of cancer patients by halting tumor progression and metastasis at any stage of cancer while synergizing with standard-of-care to overcome drug resistance and eradicate primary tumors and metastatic lesions.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- onconaut.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Onconaut?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now